Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Pre-Close Trading Statement

24 Jan 2022 07:00

RNS Number : 3047Z
Computacenter PLC
24 January 2022
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

FOR IMMEDIATE RELEASE

Computacenter plc

Pre-Close Trading Update - 24 January 2022

Computacenter plc ("Computacenter" or the "Group"), a leading independent technology partner trusted by large corporate and public sector organisations, today publishes a trading update, based on preliminary unaudited financial information, for the year ended 31 December 2021 ("the year").

Overview

Computacenter finished the year with a strong fourth quarter, ahead of our expectations. We now believe adjusted profit before tax1 for the year will be slightly in excess of £250 million and the Group will deliver its seventeenth year of uninterrupted earnings per share growth in spite of head winds from a strong pound and product supply shortages.

Financial Performance

Total revenue for the Group grew by 23 per cent including the effects of acquisitions made since the beginning of 2020, and by 27 per cent in constant currency2.

During the year we experienced the highest growth in Services revenue for the last 20 years, coupled with continued strength from Technology Sourcing product sales which was more broadly based in 2021 than the previous year.

Financial Position

The Group's adjusted3 net funds, excluding IFRS16 lease liabilities, finished extremely strongly at around £241 million. The Group is currently carrying a higher level of inventory than it would normally as we have used the strength of our balance sheet to support our customers during times of product shortages. We expect inventory to return to normal levels as supply constraints alleviate.

Group Outlook

The robustness of the business throughout 2021 and particularly the strength of the fourth quarter gives us encouragement as we enter 2022. Our product order backlog is at an all-time high and considerably larger than a year ago. This is due to two factors, product supply constraint meaning customers are ordering earlier but there is also a significant underlying strength to the market. We are pleased that the stronger Services pipeline we saw a year ago delivered increased revenue and we are hopeful of repeating this performance in 2022.

While as always there is much to do, we enter 2022 growing in multiple geographies, across product and services, which means we feel the business is well placed for another year of progress.

We look forward to publishing our final results for the year ended 31 December 2021 on Wednesday 16 March 2022.

Enquiries:

 

 

Computacenter plc

 

Mike Norris, Chief Executive

01707 631601

Tony Conophy, Finance Director

01707 631515

Tulchan Communications

 

James Macey White / Matt Low

020 7353 4200

1 Adjusted profit before tax is stated before: exceptional and other adjusting items including gain or losses on business acquisitions and disposals, and amortisation of acquired intangibles, as Management do not consider these items when reviewing the underlying performance of the Group. Further detail on the impact of exceptional and other adjusted items when compared to the non-Generally Accepted Accounting Practice financial measures, in addition to those reported in accordance with IFRS, is provided within our 2020 Annual Report and Accounts.

2 We calculate constant currency percentages by converting our prior year local currency financial results using the current year average exchange rates and comparing these recalculated amounts to our current year results or by presenting the results in the equivalent local currency amounts. Further information on this measure is included within our 2020 Annual Report and Accounts.

 3 Adjusted net funds includes cash and cash equivalents, other short or other long-term borrowings and current asset investments. Following the adoption of IFRS 16 this measure excludes all finance lease liabilities. A table reconciling this measure, including the impact of finance lease liabilities, is provided within our 2020 Annual Report and Accounts.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBJMTTMTMTTTT
Date   Source Headline
14th Sep 20204:15 pmRNSDirector/PDMR Shareholding
11th Sep 202011:00 amRNSDirector/PDMR Shareholding
9th Sep 20207:00 amRNSArrangement Agreement to Acquire IT Solutions Firm
9th Sep 20207:00 amRNSHalf-year Report
2nd Sep 20207:00 amRNSTrading Statement
6th Aug 20201:15 pmRNSBlock listing Interim Review
22nd Jul 20207:00 amRNSH1 2020 Trading Statement
15th May 20207:00 amRNSTrading Statement
14th May 20202:00 pmRNSResult of AGM
30th Apr 20205:00 pmRNSDirector/PDMR Shareholding
27th Apr 20203:31 pmRNSDisclosure of Rights Attaching to Equity Shares
27th Apr 202011:21 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSQ1 2020 Trading Update
9th Apr 20207:00 amRNS2019 Annual Report & Notice of 2020 AGM
6th Apr 20205:45 pmRNSDirector Remuneration
3rd Apr 20207:00 amRNSDirector Declaration
25th Mar 20205:00 pmRNSDirector/PDMR Shareholding
25th Mar 20204:45 pmRNSDirector/PDMR Shareholding
24th Mar 20202:00 pmRNSDirector Declaration
24th Mar 20209:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results 2019
6th Feb 20209:31 amRNSBlock listing Interim Review
23rd Jan 20207:00 amRNSPre-Close Trading Statement
17th Dec 201910:15 amRNSDirector/PDMR Shareholding
13th Dec 201910:16 amRNSNotification of Major Interest in Shares
10th Dec 20197:00 amRNSTrading Statement
4th Dec 201911:01 amRNSDirector/PDMR Shareholding
3rd Dec 20199:17 amRNSDirector/PDMR Shareholding
1st Nov 20197:00 amRNSNotification of Major Interest in Shares
30th Oct 20197:00 amRNSQ3 2019 Trading Update
23rd Oct 20193:45 pmRNSDirector/PDMR Shareholding
29th Aug 20194:30 pmRNSNotification of Major Interest in Shares
28th Aug 201910:26 amRNSDirector/PDMR Shareholding
23rd Aug 20197:00 amRNSHalf-year Report
20th Aug 20194:30 pmRNSDirectorate Change
14th Aug 20195:06 pmRNSNotification of Major Interest in Shares
6th Aug 201910:33 amRNSBlock listing Interim Review
1st Aug 20194:39 pmRNSNotification of Major Interest in Shares
31st Jul 20197:00 amRNSH1 2019 Trading Statement
29th May 20196:00 pmRNSDirector/PDMR Shareholding
16th May 20196:00 pmRNSDirectorate Change
16th May 201911:00 amRNSDirectorate Change
16th May 201910:00 amRNSResult of AGM
9th May 20195:30 pmRNSDirector/PDMR Shareholding
26th Apr 20197:00 amRNSQ1 2019 Trading Update
17th Apr 20199:45 amRNSDirector/PDMR Shareholding
12th Apr 20197:00 amRNS2018 Annual Report & Notice of 2019 AGM
4th Apr 20199:45 amRNSDirector Declaration
25th Mar 20194:30 pmRNSDirector/PDMR Shareholding
25th Mar 201912:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.